The CARDIO-TTRansform Scintigraphy Sub-study

Conditions: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Interventions: Diagnostic Test: Scintigraphy scan Sponsors: Ionis Pharmaceuticals, Inc.; AstraZeneca Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials